Literature DB >> 11559794

Frequency of spontaneous mutations in an avian hepadnavirus infection.

I Pult1, N Abbott, Y Y Zhang, J Summers.   

Abstract

In this study, we measured the frequency of revertants of a cytopathic strain of the duck hepatitis B virus that bears a single nucleotide substitution in the pre-S envelope protein open reading frame, resulting in the amino acid substitution G133E. Cytopathic virus mixed with known amounts of a genetically marked wild-type virus was injected into ducklings. Virus outgrowth was accompanied by a coselection of wild-type and spontaneous revertants during recovery of the ducklings from the acute liver injury caused by death of the G133E-infected cells. The frequency of individual revertants in the selected noncytopathic virus population was estimated by determining the ratio of each revertant to the wild-type virus. Spontaneous revertants were found to be present at frequencies of 1 x 10(-5) to 6 x 10(-5) per G133E genome inoculated. A mathematical model was used to estimate that the mutation rate was 0.8 x 10(-5) to 4.5 x 10(-5) per nucleotide per generation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11559794      PMCID: PMC114533          DOI: 10.1128/JVI.75.20.9623-9632.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

Review 1.  Naturally occurring variants of hepatitis B virus.

Authors:  S Günther; L Fischer; I Pult; M Sterneck; H Will
Journal:  Adv Virus Res       Date:  1999       Impact factor: 9.937

2.  Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus.

Authors:  J Summers; P M Smith; M J Huang; M S Yu
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

3.  Mutation rate of the hepadnavirus genome.

Authors:  R Girones; R H Miller
Journal:  Virology       Date:  1989-06       Impact factor: 3.616

4.  Sindbis virus ts103 has a mutation in glycoprotein E2 that leads to defective assembly of virions.

Authors:  C S Hahn; C M Rice; E G Strauss; E M Lenches; J H Strauss
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

5.  Genomic heterogeneity of hepatitis B virus in a 54-year-old woman who contracted the infection through materno-fetal transmission.

Authors:  H Okamoto; M Imai; M Kametani; T Nakamura; M Mayumi
Journal:  Jpn J Exp Med       Date:  1987-08

6.  Coordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus.

Authors:  R J Lenhoff; J Summers
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

7.  Construction of avian hepadnavirus variants with enhanced replication and cytopathicity in primary hepatocytes.

Authors:  R J Lenhoff; J Summers
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations.

Authors:  V K Pathak; H M Temin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

9.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.

Authors:  L M Mansky; H M Temin
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

10.  Virus-liver cell interactions in duck hepatitis B virus infection. A study of virus dissemination within the liver.

Authors:  A R Jilbert; J S Freiman; C J Burrell; M Holmes; E J Gowans; R Rowland; P Hall; Y E Cossart
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

View more
  17 in total

Review 1.  Viral mutation rates.

Authors:  Rafael Sanjuán; Miguel R Nebot; Nicola Chirico; Louis M Mansky; Robert Belshaw
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

Review 2.  Stealth and cunning: hepatitis B and hepatitis C viruses.

Authors:  Stefan F Wieland; Francis V Chisari
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Identification of a structural motif crucial for infectivity of hepatitis B viruses.

Authors:  Lars Stoeckl; Anneke Funk; Ariane Kopitzki; Boerries Brandenburg; Stefanie Oess; Hans Will; Hüseyin Sirma; Eberhard Hildt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-17       Impact factor: 11.205

4.  A high level of mutation tolerance in the multifunctional sequence encoding the RNA encapsidation signal of an avian hepatitis B virus and slow evolution rate revealed by in vivo infection.

Authors:  Bernadette Schmid; Christine Rösler; Michael Nassal
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

Review 5.  Hepadnavirus Genome Replication and Persistence.

Authors:  Jianming Hu; Christoph Seeger
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-01       Impact factor: 6.915

6.  Ultrasensitive quantification of hepatitis B virus A1762T/G1764A mutant by a SimpleProbe PCR using a wild-type-selective PCR blocker and a primer-blocker-probe partial-overlap approach.

Authors:  Hui Nie; Alison A Evans; W Thomas London; Timothy M Block; Xiangdong David Ren
Journal:  J Clin Microbiol       Date:  2011-05-11       Impact factor: 5.948

7.  Immune selection during chronic hepadnavirus infection.

Authors:  William S Mason; Sam Litwin; Allison R Jilbert
Journal:  Hepatol Int       Date:  2007-12-14       Impact factor: 6.047

8.  Rapid and sensitive detection of hepatitis B virus 1762T/1764A double mutation from hepatocellular carcinomas using LNA-mediated PCR clamping and hybridization probes.

Authors:  Xiangdong David Ren; Selena Y Lin; Xiaohe Wang; Tianlun Zhou; Timothy M Block; Ying-Hsiu Su
Journal:  J Virol Methods       Date:  2009-01-31       Impact factor: 2.014

9.  Avian and Mammalian hepadnaviruses have distinct transcription factor requirements for viral replication.

Authors:  Hong Tang; Alan McLachlan
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 10.  New perspective on the natural course of chronic HBV infection.

Authors:  Yong-Yuan Zhang; Ke-Qin Hu; Zhongping Duan
Journal:  Front Med       Date:  2014-05-29       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.